인쇄하기
취소

Clear opinion differences on controversy of the 1st Generic Exclusive Sale Rights

Published: 2014-12-15 11:11:00
Updated: 2014-12-15 11:11:00

It is known that the industry has been controversial over opinion differences on the Exclusive Sale Approval System, also known as the 1st Generic Exclusive Sale Rights, which has been taken adoption for granted as a fulfillment plan of the Patent Linkage System or a consideration of the Korea-US Free Trade Agreement.

The controversy has been triggered as Congressman Yong-ik Kim from the New P...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.